Loading...
Envision Healthcare Corporation
EVHC•NYSE
$45.99
$0.00(0.00%)

Over the last four quarters, Envision Healthcare Corporation's revenue moved from $1.99B in Q3 2017 to $2.07B in Q2 2018. Operating income in Q2 2018 was $2.14B, with a strong operating margin of 103%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Envision Healthcare Corporation remained robust at $232.70M, reflecting operational efficiency. Net income dropped to -$1.78B, with an EPS of -$14.71. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan